Literature DB >> 33589722

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.

Ping-Hsun Wu1,2,3,4, Yi-Ting Lin1,2,5,4, Yi-Wen Chiu2,6,3, Gabriel Baldanzi4, Jiun-Chi Huang1,2,3,7, Shih-Shin Liang8, Su-Chu Lee3, Szu-Chia Chen1,2,3,7, Ya-Ling Hsu9, Mei-Chuan Kuo10,11,12, Shang-Jyh Hwang2,6,3.   

Abstract

Protein-bound uremic toxins (Indoxyl sulfate [IS] and p-cresyl sulfate [PCS]) are both associated with cardiovascular (CV) and all-cause mortality in subjects with chronic kidney disease (CKD). Possible mechanisms have not been elucidated. In hemodialysis patients, we investigated the relationship between the free form of IS and PCS and 181 CV-related proteins. First, IS or PCS concentrations were checked, and high levels were associated with an increased risk of acute coronary syndrome (ACS) in 333 stable HD patients. CV proteins were further quantified by a proximity extension assay. We examined associations between the free form protein-bound uremic toxins and the quantified proteins with correction for multiple testing in the discovery process. In the second step, the independent association was evaluated by multivariable-adjusted models. We rank the CV proteins related to protein-bound uremic toxins by bootstrapped confidence intervals and ascending p-value. Six proteins (signaling lymphocytic activation molecule family member 5, complement component C1q receptor, C-C motif chemokine 15 [CCL15], bleomycin hydrolase, perlecan, and cluster of differentiation 166 antigen) were negatively associated with IS. Fibroblast growth factor 23 [FGF23] was the only CV protein positively associated with IS. Three proteins (complement component C1q receptor, CCL15, and interleukin-1 receptor-like 2) were negatively associated with PCS. Similar findings were obtained after adjusting for classical CV risk factors. However, only higher levels of FGF23 was related to increased risk of ACS. In conclusion, IS and PCS were associated with several CV-related proteins involved in endothelial barrier function, complement system, cell adhesion, phosphate homeostasis, and inflammation. Multiplex proteomics seems to be a promising way to discover novel pathophysiology of the uremic toxin.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33589722      PMCID: PMC7884394          DOI: 10.1038/s41598-021-83383-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

Review 1.  Klotho in health and disease.

Authors:  Makoto Kuro-o
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-07       Impact factor: 2.894

2.  Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients.

Authors:  Cheng-Jui Lin; Chih-Jen Wu; Chi-Feng Pan; Yi-Chou Chen; Fang-Ju Sun; Han-Hsiang Chen
Journal:  Nephrol Dial Transplant       Date:  2010-05-13       Impact factor: 5.992

3.  Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice.

Authors:  Ke Yang; Changhong Du; Xinmiao Wang; Fengju Li; Yang Xu; Song Wang; Shilei Chen; Fang Chen; Mingqiang Shen; Mo Chen; Mengjia Hu; Ting He; Yongping Su; Junping Wang; Jinghong Zhao
Journal:  Blood       Date:  2017-03-06       Impact factor: 22.113

4.  Detection and characterization of soluble CD93 released during inflammation.

Authors:  Mallary C Greenlee; Sarah A Sullivan; Suzanne Slater Bohlson
Journal:  Inflamm Res       Date:  2009-07-15       Impact factor: 4.575

5.  Bleomycin hydrolase and hyperhomocysteinemia modulate the expression of mouse proteins involved in liver homeostasis.

Authors:  Joanna Suszyńska-Zajczyk; Jacek Wróblewski; Olga Utyro; Magdalena Luczak; Lukasz Marczak; Hieronim Jakubowski
Journal:  Amino Acids       Date:  2014-03-16       Impact factor: 3.520

6.  A novel chemokine, Leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, and tissue factor expression in atherosclerosis.

Authors:  Won-Ha Lee; Se-Hwa Kim; Euy Myoung Jeong; Yoon-Ho Choi; Dong-Ik Kim; Byung Boong Lee; Young S Cho; Byoung S Kwon; Jeong-Euy Park
Journal:  Atherosclerosis       Date:  2002-04       Impact factor: 5.162

7.  ALCAM (CD166): its role in hematopoietic and endothelial development.

Authors:  O Ohneda; K Ohneda; F Arai; J Lee; T Miyamoto; Y Fukushima; D Dowbenko; L A Lasky; T Suda
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

Review 8.  Pathogenesis of beta2-microglobulin amyloidosis.

Authors:  K Ohashi
Journal:  Pathol Int       Date:  2001-01       Impact factor: 2.534

9.  Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.

Authors:  Judith Heinz; Siegfried Kropf; Claus Luley; Jutta Dierkes
Journal:  Am J Kidney Dis       Date:  2009-04-08       Impact factor: 8.860

10.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Authors:  Fellype C Barreto; Daniela V Barreto; Sophie Liabeuf; Natalie Meert; Griet Glorieux; Mohammed Temmar; Gabriel Choukroun; Raymond Vanholder; Ziad A Massy
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 8.237

View more
  4 in total

Review 1.  Dual Role of Indoles Derived From Intestinal Microbiota on Human Health.

Authors:  Xuewei Ye; Haiyi Li; Komal Anjum; Xinye Zhong; Shuping Miao; Guowan Zheng; Wei Liu; Lanjuan Li
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 2.  Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System.

Authors:  Carlos Alexandre Falconi; Carolina Victoria da Cruz Junho; Fernanda Fogaça-Ruiz; Imara Caridad Stable Vernier; Regiane Stafim da Cunha; Andréa Emilia Marques Stinghen; Marcela Sorelli Carneiro-Ramos
Journal:  Front Physiol       Date:  2021-05-14       Impact factor: 4.566

Review 3.  Recent trends in therapeutic application of engineered blood purification materials for kidney disease.

Authors:  Cui Gao; Qian Zhang; Yi Yang; Yangyang Li; Weiqiang Lin
Journal:  Biomater Res       Date:  2022-02-04

Review 4.  Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy.

Authors:  Nozomi Nagase; Yuka Ikeda; Ai Tsuji; Yasuko Kitagishi; Satoru Matsuda
Journal:  World J Diabetes       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.